MDLN

Medline Inc.
$33.69
-0.40 (-1.17%)
Mkt Cap 29.56B
Volume 8,129,290
52W Range 31.49-50.88
Sector Healthcare
Beta -0.41
EPS (TTM) 0.86 USD
P/E Ratio 39.17
Revenue (TTM) 29.94B USD
Rev Growth (5Y) +9.8%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
What we estimate one share is worth
$23.44
Overvalued strong signal
43.8% above fair value
Modeled from cash flows & growth.
AlphaQuality · Ungradable
AlphaQuality requires 5 years of audited income statements; only 4 available.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022
Revenue 28.43B 25.51B 23.23B 21.45B
Net Income 1.16B 1.20B 234.00M (25.00M)
EPS 1.43 1.52 0.30 -0.03
Free Cash Flow 1.30B 1.41B 1.40B (67.00M)
FCF / Share 1.60 1.78 1.78 -0.09
Operating CF 1.74B 1.77B 1.69B 187.00M
Total Assets 38.48B 35.98B 36.12B N/A
Total Debt 12.56B 16.90B 16.83B N/A
Cash & Equiv 1.94B 250.00M 1.58B N/A
Book Value 10.74B 16.52B 16.98B N/A
Return on Equity 0.11 0.07 0.01 N/A
MDLN News
MDLN Securities Alert: Lose Money on Your Medline Investment? BFA Law Notifies Investors of the Ongoing Securities Fraud Investigation over Product Quality Issues
Oct 09, 2026 02:33 AM · globenewswire.com
MDLN ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Potential Securities Law Violations
Oct 08, 2026 01:35 PM · newsfilecorp.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
Oct 08, 2026 06:00 AM · prnewswire.com
Medline (NASDAQ:MDLN) Stock: Insider Private Ltd Gic Sells 2,570,999 Shares
Oct 07, 2026 03:38 AM · defenseworld.net
MDLN Investor Reminder: BFA Law Reminds Medline Investors that Lost Money when Stock Dropped 13% of the Ongoing Securities Fraud Investigation
Oct 07, 2026 02:18 AM · globenewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Medline Inc. - MDLN
Oct 06, 2026 03:41 PM · globenewswire.com
Kaplan Fox is Investigating Medline Inc. (MDLN) for Investors Who Suffered Losses
Oct 06, 2026 12:50 PM · newsfilecorp.com
MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 12.8% Share Drop
Oct 06, 2026 06:00 AM · businesswire.com
Medline to report third quarter 2026 results on November 4, 2026
Oct 06, 2026 05:00 AM · globenewswire.com
MDLN Stock Notice: Medline Stock Plummeted 13% after Product Quality Issues Disclosed - Securities Fraud Investigation Underway
Oct 06, 2026 02:00 AM · gurufocus.com